These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24276640)

  • 1. Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway.
    Lee CH; Liu SY; Chou KC; Yeh CT; Shiah SG; Huang RY; Cheng JC; Yen CY; Shieh YS
    Ann Surg Oncol; 2014 Mar; 21(3):1031-7. PubMed ID: 24276640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma.
    Chiu KC; Lee CH; Liu SY; Chou YT; Huang RY; Huang SM; Shieh YS
    Oral Oncol; 2015 Jul; 51(7):683-9. PubMed ID: 25910588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl is a prognostic marker in oral squamous cell carcinoma.
    Lee CH; Yen CY; Liu SY; Chen CK; Chiang CF; Shiah SG; Chen PH; Shieh YS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S500-8. PubMed ID: 21842265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.
    Kong L; Wu Z; Zhao Y; Lu X; Shi H; Liu S; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31110076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas6 protein induces invasion and reduces inflammatory cytokines in oral squamous cell carcinoma.
    Hirschi KM; Chapman S; Hall P; Ostergar A; Winden DR; Reynolds PR; Arroyo JA
    J Oral Pathol Med; 2018 Sep; 47(8):748-754. PubMed ID: 29856094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.
    Petruzzi MN; Cherubini K; Salum FG; de Figueiredo MA
    Diagn Pathol; 2017 Apr; 12(1):32. PubMed ID: 28381274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
    Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS
    Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.
    Paccez JD; Duncan K; Vava A; Correa RG; Libermann TA; Parker MI; Zerbini LF
    Mol Biol Cell; 2015 Mar; 26(5):821-31. PubMed ID: 25568334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.
    Abboud-Jarrous G; Priya S; Maimon A; Fischman S; Cohen-Elisha M; Czerninski R; Burstyn-Cohen T
    Oncotarget; 2017 Feb; 8(8):13986-14002. PubMed ID: 28118606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas6/Axl signaling attenuates alveolar inflammation in ischemia-reperfusion-induced acute lung injury by up-regulating SOCS3-mediated pathway.
    Peng CK; Wu CP; Lin JY; Peng SC; Lee CH; Huang KL; Shen CH
    PLoS One; 2019; 14(7):e0219788. PubMed ID: 31318922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway.
    Li M; Ye J; Zhao G; Hong G; Hu X; Cao K; Wu Y; Lu Z
    Int J Mol Med; 2019 Sep; 44(3):982-994. PubMed ID: 31524235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis.
    Lee WP; Wen Y; Varnum B; Hung MC
    Oncogene; 2002 Jan; 21(3):329-36. PubMed ID: 11821945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition.
    Kong L; Lu X; Chen X; Wu Y; Zhang Y; Shi H; Li J
    Aging (Albany NY); 2020 May; 12(10):9714-9725. PubMed ID: 32432570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.
    Tanaka M; Siemann DW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma.
    Bae CA; Ham IH; Oh HJ; Lee D; Woo J; Son SY; Yoon JH; Lorens JB; Brekken RA; Kim TM; Han SU; Park WS; Hur H
    Gastric Cancer; 2020 Sep; 23(5):824-836. PubMed ID: 32239298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages.
    Gustafsson A; Fritz HKM; Dahlbäck B
    Exp Cell Res; 2017 Jun; 355(1):47-56. PubMed ID: 28327411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.